NOVÁKOVÁ, Olga, Ctirad HOFR and Viktor BRABEC. Modification of natural, double-helical DNA by antitumor cis- and trans-[Cl2(Me2SO4)4Ru] in cell-free media. Biochemical Pharmacology. Oxford, UK: Elsevier, 2000, vol. 60, No 12, p. 1761-1771. ISSN 0006-2952.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Modification of natural, double-helical DNA by antitumor cis- and trans-[Cl2(Me2SO4)4Ru] in cell-free media
Authors NOVÁKOVÁ, Olga, Ctirad HOFR and Viktor BRABEC.
Edition Biochemical Pharmacology, Oxford, UK, Elsevier, 2000, 0006-2952.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10610 Biophysics
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.975
RIV identification code RIV/00216224:14310/00:00003418
Organization unit Faculty of Science
Changed by Changed by: prof. RNDr. Viktor Brabec, DrSc., učo 46787. Changed: 27/2/2001 09:53.
Abstract
Modifications of natural DNA in cell-free media by antitumor ruthenium compounds, cis- and trans-[Cl2(Me2SO4)4Ru] were studied by various biochemical and biophysical methods. The results indicated that both ruthenium compounds irreversibly coordinated to DNA. Several features of DNA binding mode of trans-[Cl2(Me2SO4)4Ru] were similar to those of antitumor cisplatin, which may be relevant to biological effects of this antitumor ruthenium drug. On the other hand, the different DNA binding mode of cis-[Cl2(Me2SO4)4Ru] was consistent with its less pronounced biological effects.
Links
GA305/99/0695, research and development projectName: Ovlivnění konformace DNA protinádorově účinnými komplexy kovů. Vztah k vývoji nových cytostatik.
PrintDisplayed: 6/5/2024 18:22